Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

The reference epigenome and regulatory chromatin landscape of chronic lymphocytic leukemia.

Authors:
Renée Beekman Vicente Chapaprieta Núria Russiñol Roser Vilarrasa-Blasi Núria Verdaguer-Dot Joost H A Martens Martí Duran-Ferrer Marta Kulis François Serra Biola M Javierre Steven W Wingett Guillem Clot Ana C Queirós Giancarlo Castellano Julie Blanc Marta Gut Angelika Merkel Simon Heath Anna Vlasova Sebastian Ullrich Emilio Palumbo Anna Enjuanes David Martín-García Sílvia Beà Magda Pinyol Marta Aymerich Romina Royo Montserrat Puiggros David Torrents Avik Datta Ernesto Lowy Myrto Kostadima Maša Roller Laura Clarke Paul Flicek Xabier Agirre Felipe Prosper Tycho Baumann Julio Delgado Armando López-Guillermo Peter Fraser Marie-Laure Yaspo Roderic Guigó Reiner Siebert Marc A Martí-Renom Xose S Puente Carlos López-Otín Ivo Gut Hendrik G Stunnenberg Elias Campo Jose I Martin-Subero

Nat Med 2018 06 21;24(6):868-880. Epub 2018 May 21.

Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.

Chronic lymphocytic leukemia (CLL) is a frequent hematological neoplasm in which underlying epigenetic alterations are only partially understood. Here, we analyze the reference epigenome of seven primary CLLs and the regulatory chromatin landscape of 107 primary cases in the context of normal B cell differentiation. We identify that the CLL chromatin landscape is largely influenced by distinct dynamics during normal B cell maturation. Beyond this, we define extensive catalogues of regulatory elements de novo reprogrammed in CLL as a whole and in its major clinico-biological subtypes classified by IGHV somatic hypermutation levels. We uncover that IGHV-unmutated CLLs harbor more active and open chromatin than IGHV-mutated cases. Furthermore, we show that de novo active regions in CLL are enriched for NFAT, FOX and TCF/LEF transcription factor family binding sites. Although most genetic alterations are not associated with consistent epigenetic profiles, CLLs with MYD88 mutations and trisomy 12 show distinct chromatin configurations. Furthermore, we observe that non-coding mutations in IGHV-mutated CLLs are enriched in H3K27ac-associated regulatory elements outside accessible chromatin. Overall, this study provides an integrative portrait of the CLL epigenome, identifies extensive networks of altered regulatory elements and sheds light on the relationship between the genetic and epigenetic architecture of the disease.

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41591-018-0028-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6363101PMC
June 2018

Publication Analysis

Top Keywords

chromatin landscape
12
regulatory elements
12
chronic lymphocytic
8
lymphocytic leukemia
8
regulatory chromatin
8
normal cell
8
reference epigenome
8
chromatin
6
regulatory
5
cll
5
tcf/lef transcription
4
fox tcf/lef
4
cll enriched
4
active regions
4
regions cll
4
transcription factor
4
enriched nfat
4
nfat fox
4
binding sites
4
alterations associated
4

Altmetric Statistics


Show full details
224 Total Shares
3 Facebook Pages
1 Blogs
9 News Outlets
174 Tweets
1 Wikipedia Pages
188 Citations

Similar Publications

Downregulated METTL14 accumulates BPTF that reinforces super-enhancers and distal lung metastasis via glycolytic reprogramming in renal cell carcinoma.

Authors:
Chuanjie Zhang Li Chen Yihan Liu Jingyi Huang Ao Liu Yang Xu Yan Shen Hongchao He Danfeng Xu

Theranostics 2021 26;11(8):3676-3693. Epub 2021 Jan 26.

Department of Urology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.

Methyltransferase-like 14 (METTL14) participates in tumorigenesis in several malignancies, but how METTL14 mediates the metastasis of renal cell carcinoma (RCC) has never been reported. Western blotting, quantitative real-time PCR, and immunohistochemistry were used to determine the mRNA and protein levels of relevant genes. Methylated RNA immunoprecipitation sequencing and RNA sequencing were utilized to screen potential targets of METTL14. Read More

View Article and Full-Text PDF
January 2021
Similar Publications

Transcriptome and chromatin landscape of iNKT cells are shaped by subset differentiation and antigen exposure.

Authors:
Mallory Paynich Murray Isaac Engel Grégory Seumois Sara Herrera-De la Mata Sandy Lucette Rosales Ashu Sethi Ashmitaa Logandha Ramamoorthy Premlal Goo-Young Seo Jason Greenbaum Pandurangan Vijayanand James P Scott-Browne Mitchell Kronenberg

Nat Commun 2021 03 4;12(1):1446. Epub 2021 Mar 4.

La Jolla Institute for Immunology, La Jolla, CA, USA.

Invariant natural killer T cells (iNKT cells) differentiate into thymic and peripheral NKT1, NKT2 and NKT17 subsets. Here we use RNA-seq and ATAC-seq analyses and show iNKT subsets are similar, regardless of tissue location. Lung iNKT cell subsets possess the most distinct location-specific features, shared with other innate lymphocytes in the lung, possibly consistent with increased activation. Read More

View Article and Full-Text PDF
March 2021
Similar Publications

Bromodomain protein BRDT directs ΔNp63 function and super-enhancer activity in a subset of esophageal squamous cell carcinomas.

Authors:
Xin Wang Ana P Kutschat Moyuru Yamada Evangelos Prokakis Patricia Böttcher Koji Tanaka Yuichiro Doki Feda H Hamdan Steven A Johnsen

Cell Death Differ 2021 Mar 3. Epub 2021 Mar 3.

Department of General, Visceral and Pediatric Surgery, University Medical Center Göttingen, Göttingen, Germany.

Esophageal squamous cell carcinoma (ESCC) is the predominant subtype of esophageal cancer with a particularly high prevalence in certain geographical regions and a poor prognosis with a 5-year survival rate of 15-25%. Despite numerous studies characterizing the genetic and transcriptomic landscape of ESCC, there are currently no effective targeted therapies. In this study, we used an unbiased screening approach to uncover novel molecular precision oncology targets for ESCC and identified the bromodomain and extraterminal (BET) family member bromodomain testis-specific protein (BRDT) to be uniquely expressed in a subgroup of ESCC. Read More

View Article and Full-Text PDF
March 2021
Similar Publications

upregulation is associated with chromatin remodeling in gastric cancer and induction of tumorigenicity in a xenograft mouse model.

Authors:
Dong Hyuck Bae Hee-Jin Kim Byoung-Ha Yoon Jong-Lyul Park Mirang Kim Seon-Kyu Kim Seon-Young Kim Sang-Il Lee Kyu-Sang Song Yong Sung Kim

Oncol Rep 2021 Apr 2;45(4). Epub 2021 Mar 2.

Genome Editing Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon 34141, Republic of Korea.

Pathological changes in the epigenetic landscape of chromatin are hallmarks of cancer. Our previous study showed that global methylation of promoters may increase or decrease during the transition from gastric mucosa to intestinal metaplasia (IM) to gastric cancer (GC). Here, CpG hypomethylation of the serine/threonine kinase promoter in IM and GC was detected in a reduced representation bisulfite sequencing database. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

Oncohistone mutations enhance chromatin remodeling and alter cell fates.

Authors:
John D Bagert Michelle M Mitchener Agata L Patriotis Barbara E Dul Felix Wojcik Benjamin A Nacev Lijuan Feng C David Allis Tom W Muir

Nat Chem Biol 2021 Mar 1. Epub 2021 Mar 1.

Department of Chemistry, Princeton University, Princeton, NJ, USA.

Whole-genome sequencing data mining efforts have revealed numerous histone mutations in a wide range of cancer types. These occur in all four core histones in both the tail and globular domains and remain largely uncharacterized. Here we used two high-throughput approaches, a DNA-barcoded mononucleosome library and a humanized yeast library, to profile the biochemical and cellular effects of these mutations. Read More

View Article and Full-Text PDF
March 2021
Similar Publications
© 2021 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap